Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: Arthritis Rheum. 2011 Nov;63(11):3274–3283. doi: 10.1002/art.30573

FIGURE 3. The CXCR3 small antagonist AMG487 decreases invasion of both DA and RA FLS.

FIGURE 3

(A) DA (n=8; *P≤0.001, t-test) and (B) RA (n=6; *P≤0.001, t-test; mean±S.D.) FLS invasion was significantly reduced by 77% and 58%, respectively, with AMG487 10μM treatment, compared with control.